Skip to main content

Table 4 Genes composing the prognostic methylation signature for the 45 stage IIIC CM patients

From: Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients

TargetID1

GENE ID2

SYMBOL3

Distance to TSS4

CPG ISLAND5

cg00498305

6571

SLC18A2

480

TRUE

cg01333788

2709

GJB5

93

FALSE

cg02064402

348932

SLC6A18

249

FALSE

cg02415431

3543

IGLL1

760

FALSE

cg03742272

242

ALOX12B

316

FALSE

cg05164634

7480

WNT10B

995

TRUE

cg05492113

7275

TUB

152

FALSE

cg07039113

6280

S100A9

1317

FALSE

cg08929103

1394

CRHR1

1331

FALSE

cg09196959

135644

TRIM40

70

FALSE

cg09395732

6538

SLC6A11

461

TRUE

cg14236389

284756

FLJ33860

58

TRUE

cg14578030

2249

FGF4

1212

FALSE

cg16139316

6280

S100A9

428

FALSE

cg22088368

339669

MGC35206

1049

FALSE

cg24076884

56134

PCDHAC2

569

TRUE

cg26424956

2914

GRM4

83

FALSE

  1. 1 Illumina unique probe identifier;
  2. 2 Unique NCBI's Entrez Gene record (gene identifier) for the gene;
  3. 3 unique gene symbol as established by the HUGO Gene Nomenclature Committee;
  4. 4 distance in base pairs from the putative transcription start site of the gene;
  5. 5 location of the assayed CpG site in a region fulfilling the definition of CpG island.